Src and Rac mediate endothelin-1 and lysophosphatidic acid stimulation of the human brain natriuretic peptide promoter

被引:26
|
作者
He, Q [1 ]
LaPointe, MC [1 ]
机构
[1] Henry Ford Hosp, Div Hypertens & Vasc Res, Detroit, MI 48202 USA
关键词
cardiomyocytes; genes; brain natriuretic peptide; endothelin; phospholipases;
D O I
10.1161/01.HYP.37.2.478
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Brain natriuretic peptide (BNP) gene expression accompanies cardiac hypertrophy and heart failure. The vasoconstrictor endothelin-1 (ET) may be involved in the development of these diseases. ET has also been shown to activate phospholipase A(2) (PLA(2)), and the resulting metabolites are important second messengers. We studied how ET and PLA(2) metabolites regulate BNP gene expression. The human BNP (hBNP) promoter (from -1818 to +100) coupled to a luciferase reporter gene was transferred into neonatal ventricular myocytes (NVMs), and luciferase activity was measured as an index of promoter activity. ET induced BNP mRNA in NVMs as assessed by Northern blot. It also stimulated the hBNP promoter, an effect completely inhibited by actinomycin D. To test the involvement of different PLA(2) isoforms, transfected cells were treated with various PLA(2) inhibitors before stimulation with ET. Only Ca2+-independent PLA(2) blockade prevented ET-stimulated hBNP promoter activity. The PLA(2) metabolite lysophosphatidic acid (LPA) also activated the hBNP promoter, but arachidonic acid itself did not. ET regulation of the hBNP promoter is pertussis toxin-sensitive. The nonreceptor tyrosine kinase Src and the small GTPase Rac mediate the effects of both ET and LPA in stimulation of the hBNP promoter. We studied the involvement of cis elements in ET-stimulated hBNP promoter activity. Deletion of BNP promoter sequences from -1818 to -408 and from -408 to -40 reduced the effect of ET by 60% and 80%, respectively, Moreover, ET-stimulated luciferase activity was reduced by 50% when the proximal GATA element was mutated. These data suggest that (1) ET activates the hBNP promoter through a transcriptional mechanism; (2) LPA, perhaps generated by iPLA(2), is involved in the effect of ET; (3) Src and Rac mediate ET and LPA stimulation of the hBNP promoter; and (4) ET regulation of the hBNP promoter targets both distal and proximal cis elements.
引用
收藏
页码:478 / 484
页数:7
相关论文
共 50 条
  • [21] Changes of endothelin-1 and atrial natriuretic peptide during dobutamine stress echocardiography
    Cherng, WJ
    Wang, CH
    Hung, MJ
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1998, 97 (12) : 812 - 818
  • [22] DIPSOGENIC ACTION OF BRAIN NATRIURETIC PEPTIDE AND ENDOTHELIN-1 IN THE JAPANESE-QUAIL, COTURNIX-COTURNIX-JAPONICA
    TEZUKA, Y
    KOBAYASHI, H
    UEMURA, H
    ZOOLOGICAL SCIENCE, 1992, 9 (03) : 619 - 624
  • [23] Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans
    DeFeo, ML
    LaVilla, G
    Lazzeri, C
    TostiGuerra, C
    Becorpi, A
    Pupilli, C
    Mannelli, M
    HYPERTENSION, 1997, 29 (01) : 70 - 74
  • [24] Identification of the thrombin regulatory region of the human endothelin-1 promoter
    Visner, GA
    Garlington, W
    Gan, LX
    Nick, HS
    PEDIATRIC RESEARCH, 2000, 47 (04) : 483A - 483A
  • [25] ATRIAL-NATRIURETIC-PEPTIDE REVERSES BUT DOES NOT PROTECT AGAINST CHALLENGE WITH ENDOTHELIN-1 IN ISOLATED HUMAN BRONCHI
    CLAYTON, RA
    NALLY, JE
    THOMSON, NC
    MCGRATH, JC
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P425 - P425
  • [26] HUMAN BRAIN CONTAINS A METALLOPROTEASE THAT CONVERTS BIG ENDOTHELIN-1 TO ENDOTHELIN-1 AND IS INHIBITED BY PHOSPHORAMIDON AND EDTA
    WARNER, TD
    SCHMIDT, HHHW
    KUK, J
    MITCHELL, JA
    MURAD, F
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (03) : 505 - 506
  • [27] Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: The dependence on the selected morphological parameters
    Irzmanski, Robert
    Banach, Maciej
    Piechota, Mariusz
    Kowalski, Jan
    Barylski, Marcin
    Cierniewski, Czeslaw
    Pawlicki, Lucjan
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2007, 29 (03) : 149 - 164
  • [28] Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease
    Yeh, JL
    Hsu, JH
    Dai, ZK
    Liou, SF
    Chen, IJ
    Wu, JR
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 104 (01) : 15 - 20
  • [29] Plasma endothelin-1 and natriuretic peptide levels and antioxidant capacity of heart transplanted patients
    I Olejarova
    k Danova
    H Minarova
    V Fischer
    V Rendekova
    J Fabian
    I Pechan
    Critical Care, 4 (Suppl 1):
  • [30] LOW-DOSES OF ENDOTHELIN-1 INHIBIT ATRIAL-NATRIURETIC-PEPTIDE SECRETION
    SHIRAKAMI, G
    NAKAO, K
    SAITO, Y
    MAGARIBUCHI, T
    MUKOYAMA, M
    ARAI, H
    HOSODA, K
    SUGA, S
    MORI, K
    IMURA, H
    ENDOCRINOLOGY, 1993, 132 (05) : 1905 - 1912